Hengehold Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.01M Sell
27,583
-136
-0.5% -$31.7K 0.54% 40
2026
Q1
$6.78M Buy
27,719
+352
+1% +$82K 0.59% 39
2025
Q4
$5.66M Buy
27,367
+683
+3% +$135K 0.48% 45
2025
Q3
$4.95M Buy
26,684
+585
+2% +$100K 0.42% 49
2025
Q2
$3.99M Buy
26,099
+53
+0.2% +$8.15K 0.36% 54
2025
Q1
$4.32M Buy
26,046
+1,044
+4% +$163K 0.41% 50
2024
Q4
$3.62M Buy
25,002
+334
+1% +$51.8K 0.34% 57
2024
Q3
$4M Buy
24,668
+582
+2% +$92.7K 0.38% 54
2024
Q2
$3.52M Buy
24,086
+4,984
+26% +$741K 0.37% 53
2024
Q1
$3.02M Sell
19,102
-127
-0.7% -$20.2K 0.32% 60
2023
Q4
$3.01M Buy
19,229
+505
+3% +$77.4K 0.36% 55
2023
Q3
$2.92M Buy
18,724
+191
+1% +$31.5K 0.38% 55
2023
Q2
$3.07M Buy
18,533
+300
+2% +$48.4K 0.41% 51
2023
Q1
$2.83M Sell
18,233
-486
-3% -$78.5K 0.39% 53
2022
Q4
$3.31M Buy
18,719
+2,066
+12% +$357K 0.46% 46
2022
Q3
$2.72M Buy
16,653
+503
+3% +$85.1K 0.42% 46
2022
Q2
$2.87M Buy
16,150
+748
+5% +$133K 0.41% 41
2022
Q1
$2.73M Sell
15,402
-422
-3% -$71.8K 0.37% 45
2021
Q4
$2.71M Buy
15,824
+1,013
+7% +$166K 0.33% 43
2021
Q3
$2.39M Buy
14,811
+303
+2% +$51.7K 0.32% 47
2021
Q2
$2.39M Buy
14,508
+488
+3% +$80.8K 0.31% 48
2021
Q1
$2.3M Buy
14,020
+146
+1% +$23.6K 0.32% 47
2020
Q4
$2.18M Sell
13,874
-163
-1% -$24.1K 0.32% 40
2020
Q3
$2.09M Buy
14,037
+599
+4% +$88.6K 0.34% 40
2020
Q2
$1.89M Sell
13,438
-132
-1% -$19.2K 0.34% 40
2020
Q1
$1.78M Sell
13,570
-5,479
-29% -$777K 0.38% 35
2019
Q4
$2.78M Sell
19,049
-1,024
-5% -$139K 0.47% 32
2019
Q3
$2.6M Buy
20,073
+767
+4% +$101K 0.48% 36
2019
Q2
$2.69M Sell
19,306
-1,129
-6% -$156K 0.52% 35
2019
Q1
$2.86M Sell
20,435
-160
-0.8% -$21.4K 0.67% 30
2018
Q4
$2.66M Buy
20,595
+21
+0.1% +$2.93K 0.85% 26
2018
Q3
$2.84M Buy
20,574
+3,056
+17% +$406K 0.71% 27
2018
Q2
$2.13M Buy
17,518
+209
+1% +$26.1K 0.55% 37
2018
Q1
$2.22M Sell
17,309
-235
-1% -$31.8K 0.58% 36
2017
Q4
$2.45M Sell
17,544
-666
-4% -$92.8K 0.64% 32
2017
Q3
$2.37M Buy
18,210
+115
+0.6% +$15.2K 0.63% 29
2017
Q2
$2.39M Sell
18,095
-3,010
-14% -$384K 0.67% 26
2017
Q1
$2.63M Sell
21,105
-1,348
-6% -$161K 0.73% 29
2016
Q4
$2.59M Sell
22,453
-398
-2% -$46K 0.79% 25
2016
Q3
$2.7M Sell
22,851
-3,896
-15% -$473K 0.86% 21
2016
Q2
$3.24M Sell
26,747
-799
-3% -$90.8K 1.06% 19
2016
Q1
$2.98M Buy
27,546
+187
+0.7% +$19.4K 0.96% 20
2015
Q4
$2.81M Sell
27,359
-340
-1% -$34.2K 1.01% 22
2015
Q3
$2.59M Buy
27,699
+2,484
+10% +$240K 1.12% 19
2015
Q2
$2.46M Sell
25,215
-1,598
-6% -$160K 0.88% 19
2015
Q1
$2.7M Sell
26,813
-447
-2% -$45.5K 0.93% 17
2014
Q4
$2.85M Buy
27,260
+433
+2% +$45.6K 1.01% 15
2014
Q3
$2.86M Sell
26,827
-3,405
-11% -$353K 0.97% 19
2014
Q2
$3.16M Sell
30,232
-34
-0.1% -$3.44K 1.06% 17
2014
Q1
$2.97M Buy
30,266
+441
+1% +$40.9K 1.01% 18
2013
Q4
$2.73M Sell
29,825
-570
-2% -$52.5K 0.95% 20
2013
Q3
$2.63M Sell
30,395
-1,358
-4% -$122K 1.05% 18
2013
Q2
$2.73M Buy
+31,753
New +$2.69M 1.18% 16

Other funds holding JNJ

Hengehold Capital Management's JNJ Position: Q2 2026 in Review

Hengehold Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.49% in Q2 2026, selling an estimated $31.7K and leaving 27,583 shares worth $7.01M. The position accounts for 0.54% of the portfolio, ranked #40.

Hengehold Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hengehold Capital Management held 27,583 shares of Johnson & Johnson worth $7.01M as of Q2 2026.
  • Hengehold Capital Management sold 136 Johnson & Johnson shares in Q2 2026, an estimated $31.7K.
  • Johnson & Johnson made up 0.54% of Hengehold Capital Management's portfolio in Q2 2026, its #40 holding.
  • Hengehold Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hengehold Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.